{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:47:45Z","timestamp":1794890865606,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01988-z","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:18:49Z","timestamp":1752466729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Non-linear association between metabolic score for insulin resistance and nonalcoholic fatty liver disease: analysis of US National health and nutrition examination survey data, 2017\u20132020"],"prefix":"10.1186","volume":"25","author":[{"given":"Shanshan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"1988_CR1","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11154-023-09843-z","volume":"24","author":"M Jayachandran","year":"2023","unstructured":"Jayachandran M, Qu S. Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies. Rev Endocr Metab Disord. 2023;24:1189\u2013204.","journal-title":"Rev Endocr Metab Disord"},{"key":"1988_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","volume":"378","author":"BA Swinburn","year":"2011","unstructured":"Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804\u201314.","journal-title":"Lancet"},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1988_CR4","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158:1851\u201364.","journal-title":"Gastroenterology"},{"key":"1988_CR5","doi-asserted-by":"publisher","first-page":"e30387","DOI":"10.1016\/j.heliyon.2024.e30387","volume":"10","author":"AM Samy","year":"2024","unstructured":"Samy AM, Kandeil MA, Sabry D, Abdel-Ghany AA, Mahmoud MO. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences. Heliyon. 2024;10:e30387.","journal-title":"Heliyon"},{"key":"1988_CR6","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N. Japan study group of Nafld J-N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21:3863.","journal-title":"Int J Mol Sci"},{"key":"1988_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","volume":"35","author":"CS Tam","year":"2012","unstructured":"Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care. 2012;35:1605\u201310.","journal-title":"Diabetes Care"},{"key":"1988_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1258\/000456307780945778","volume":"44","author":"A Borai","year":"2007","unstructured":"Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance. Ann Clin Biochem. 2007;44:324\u201342.","journal-title":"Ann Clin Biochem"},{"key":"1988_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178:533\u201344.","journal-title":"Eur J Endocrinol"},{"key":"1988_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/jdi.14024","volume":"14","author":"L Pan","year":"2023","unstructured":"Pan L, Zou H, Meng X, Li D, Li W, Chen X, et al. Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: results from the 4\u00a0C cohort study. J Diabetes Investig. 2023;14:961\u201372.","journal-title":"J Diabetes Investig"},{"key":"1988_CR11","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.2147\/DMSO.S476398","volume":"17","author":"X Ma","year":"2024","unstructured":"Ma X, Ji B, Du W, Shi S, Zhao H, Sheng J, et al. METS-IR, a novel simple insulin resistance index, is associated with NAFLD in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2024;17:3481\u201390.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1988_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3350\/cmh.2022.0099","volume":"28","author":"JH Lee","year":"2022","unstructured":"Lee JH, Park K, Lee HS, Park HK, Han JH, Ahn SB. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol. 2022;28:814\u201326.","journal-title":"Clin Mol Hepatol"},{"key":"1988_CR13","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.3390\/nu15194128","volume":"15","author":"J Pan","year":"2023","unstructured":"Pan J, Hu Y, Pang N, Yang L. Association between dietary niacin intake and nonalcoholic fatty liver disease: NHANES 2003\u20132018. Nutrients. 2023;15:4128.","journal-title":"Nutrients"},{"key":"1988_CR14","doi-asserted-by":"publisher","first-page":"4930355","DOI":"10.1155\/2022\/4930355","volume":"2022","author":"X Cai","year":"2022","unstructured":"Cai X, Gao J, Hu J, Wen W, Zhu Q, Wang M, et al. Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a Nonobese Chinese population: retrospective evidence from a population-based cohort study. Dis Markers. 2022;2022:4930355.","journal-title":"Dis Markers"},{"key":"1988_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:156\u2013e1632.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1988_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.2147\/DMSO.S409983","volume":"16","author":"H Li","year":"2023","unstructured":"Li H, Shi Z, Chen X, Wang J, Ding J, Geng S, et al. Relationship between six insulin resistance surrogates and nonalcoholic fatty liver disease among older adults: a cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:1685\u201396.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1988_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"1988_CR18","doi-asserted-by":"publisher","first-page":"6591784","DOI":"10.1155\/2021\/6591784","volume":"2021","author":"LZ Chen","year":"2021","unstructured":"Chen LZ, Jing XB, Wu CF, Zeng YC, Xie YC, Wang MQ, et al. Nonalcoholic fatty liver disease-associated liver fibrosis is linked with the severity of coronary artery disease mediated by systemic inflammation. Dis Markers. 2021;2021:6591784.","journal-title":"Dis Markers"},{"key":"1988_CR19","doi-asserted-by":"publisher","first-page":"15489","DOI":"10.3390\/ijms232415489","volume":"23","author":"X Guo","year":"2022","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022;23:15489.","journal-title":"Int J Mol Sci"},{"key":"1988_CR20","doi-asserted-by":"publisher","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","volume":"13","author":"L Rong","year":"2022","unstructured":"Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne). 2022;13:1087260. https:\/\/doi.org\/10.3389\/fendo.2022.1087260.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1988_CR21","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.2147\/DMSO.S438975","volume":"16","author":"Y Shu","year":"2023","unstructured":"Shu Y, Huang G, Mao Y. The metabolic score for insulin resistance index is superior to the triglyceride and glucose index in identifying nonalcoholic fatty liver disease in hyperuricemia subjects. Diabetes Metab Syndr Obes. 2023;16:4235\u201346.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1988_CR22","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.2147\/IJGM.S319759","volume":"14","author":"L Ji","year":"2021","unstructured":"Ji L, Cai X, Bai Y, Li T. Application of a novel prediction model for predicting 2-year risk of non-alcoholic fatty liver disease in the non-obese population with normal blood lipid levels: a large prospective cohort study from China. Int J Gen Med. 2021;14:2909\u201322.","journal-title":"Int J Gen Med"},{"key":"1988_CR23","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","volume":"23","author":"A Lonardo","year":"2017","unstructured":"Lonardo A, Nascimbeni F, Maurantonio M, Marrazzo A, Rinaldi L, Adinolfi LE. Nonalcoholic fatty liver disease: evolving paradigms. World J Gastroenterol. 2017;23:6571\u201392.","journal-title":"World J Gastroenterol"},{"key":"1988_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14:99\u2013114.","journal-title":"Nat Rev Endocrinol"},{"key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.28985","volume":"65","author":"F Bril","year":"2017","unstructured":"Bril F, Barb D, Portillo-Sanchez P, Biernacki D, Lomonaco R, Suman A, et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology. 2017;65:1132\u201344.","journal-title":"Hepatology"},{"key":"1988_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, et al. Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord. 2022;22:63.","journal-title":"BMC Endocr Disord"},{"key":"1988_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","volume":"42","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Adipose tissue, obesity and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42:92\u2013108.","journal-title":"Minerva Endocrinol"},{"key":"1988_CR28","first-page":"1081","volume":"12","author":"A Ntikoudi","year":"2024","unstructured":"Ntikoudi A, Spyrou A, Evangelou E, Dokoutsidou E, Mastorakos G. The effect of menopausal status, insulin resistance and body mass index on the prevalence of non-alcoholic fatty liver disease. Healthc (Basel). 2024;12:1081.","journal-title":"Healthc (Basel)"},{"key":"1988_CR29","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69:2672\u201382.","journal-title":"Hepatology"},{"key":"1988_CR30","doi-asserted-by":"publisher","first-page":"dgaa583","DOI":"10.1210\/clinem\/dgaa583","volume":"105","author":"A Morandi","year":"2020","unstructured":"Morandi A, Di Sessa A, Zusi C, Umano GR, El Mazloum D, Fornari E, et al. Nonalcoholic fatty liver disease and estimated insulin resistance in obese youth: a Mendelian randomization analysis. J Clin Endocrinol Metab. 2020;105:dgaa583.","journal-title":"J Clin Endocrinol Metab"},{"key":"1988_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u201333.","journal-title":"Hepatology"},{"key":"1988_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3904\/kjim.2007.22.4.270","volume":"22","author":"SY Rhee","year":"2007","unstructured":"Rhee SY, Kwon MK, Park BJ, Chon S, Jeong IK, Oh S, et al. Differences in insulin sensitivity and secretory capacity based on OGTT in subjects with impaired glucose regulation. Korean J Intern Med. 2007;22:270\u20134.","journal-title":"Korean J Intern Med"},{"key":"1988_CR33","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1111\/dom.13447","volume":"20","author":"E Roh","year":"2018","unstructured":"Roh E, Kim KM, Park KS, Kim YJ, Chun EJ, Choi SH, et al. Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans. Diabetes Obes Metab. 2018;20:2642\u201352.","journal-title":"Diabetes Obes Metab"},{"key":"1988_CR34","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.3390\/ijms23094744","volume":"23","author":"A Mietelska-Porowska","year":"2022","unstructured":"Mietelska-Porowska A, Doma\u0144ska J, Want A, Wi\u0119ckowska-Gacek A, Chutora\u0144ski D, Koperski M, Wojda U. Induction of brain insulin resistance and alzheimer\u2019s molecular changes by Western diet. Int J Mol Sci. 2022;23:4744.","journal-title":"Int J Mol Sci"},{"key":"1988_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/ijms20020298","volume":"20","author":"HW Chao","year":"2019","unstructured":"Chao HW, Chao SW, Lin H, Ku HC, Cheng CF. Homeostasis of glucose and lipid in Non-Alcoholic fatty liver disease. Int J Mol Sci. 2019;20:298.","journal-title":"Int J Mol Sci"},{"key":"1988_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12876-025-03833-y","volume":"25","author":"C Xie","year":"2025","unstructured":"Xie C, Chen X, Zhang J, Jiang X, Xu J, Lin H. Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease. BMC Gastroenterol. 2025;25:238.","journal-title":"BMC Gastroenterol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01988-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:24:30Z","timestamp":1757240670000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01988-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01988-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey protocol received ethical approval from the National Center for Health Statistics Institutional Review Board, and all procedures were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"172"}}